Siemens Healthineers stock gains analyst support as JPMorgan sticks to Overweight

Published on 09/09/2026 at 12:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Siemens Healthineers stock is rated Overweight by JPMorgan as of September 9, 2026, underlining confidence despite a challenging medtech backdrop. The shares most recently traded around EUR 38.61 on Xetra, close to the EUR 38.55 level noted on September 4, 2026.

Editorial-Foto eines Trading-Floors mit Healthcare-Sektor-Charts und DAX-Anzeige — Siemens Healthineers DE000SHL1006 dokumentiert Börsen-Editorial mit Trading-Floor, Healthcare-Charts und DAX-Kursanzeige im Hintergrund, Illustration mit AI erstellt.

Siemens Healthineers stock (ISIN DE000SHL1006) is backed by fresh analyst support, with JPMorgan reaffirming its Overweight stance on September 9, 2026 while the shares most recently changed hands near EUR 38.61 on Xetra, only a fraction above the EUR 38.55 level recorded on September 4, 2026.

JPMorgan keeps Overweight rating

According to finanzen.ch on September 9, 2026, JPMorgan Chase and Co. reiterated its Overweight rating on Siemens Healthineers, highlighting that its analysts remain cautious on the broader European medtech sector but see the company as relatively well positioned.

The same overview from finanzen.ch shows the stock at EUR 38.61 on September 9, 2026 compared with EUR 38.55 on September 4, 2026, implying a modest gain of about 0.2 percent over that period.

Analyst landscape and recent targets

The analyst table compiled by finanzen.ch also documents a Buy rating from Jefferies on Siemens Healthineers dated August 4, 2026, adding another positive voice to the coverage even though no explicit price target is listed in that snippet.

Earlier, JPMorgan had already rated Siemens Healthineers Overweight on August 3, 2026 in the same overview from finanzen.ch, indicating that the latest confirmation on September 9, 2026 maintains a constructive stance rather than marking a shift in view.

Stock level and investor angle

Per the analyst snapshot on finanzen.ch, Siemens Healthineers stock is shown with a current price of EUR 38.61 on Xetra on September 9, 2026 versus an indicated EUR 38.55 reference level, placing the share slightly above that recent mark and underlining that the confirmation of the Overweight rating comes without a sharp short-term price move.

The same overview lists the valuation metric price earnings ratio (KGV) as not available in the snippet, which means investors will focus more on the qualitative message from the Overweight rating and the broader medtech backdrop described by JPMorgan rather than on a single valuation number in this context, as indicated by finanzen.ch.

Siemens Healthineers share price snapshot

On Xetra, Siemens Healthineers stock most recently traded at around EUR 38.61 on September 9, 2026, with the prior level of EUR 38.55 noted in the same analyst context on September 4, 2026, marking a small upward move that broadly aligns with the stable Overweight stance from JPMorgan.